Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation.

Dezzutti CS, Russo J, Wang L, Abebe KZ, Li J, Friend DR, McGowan IM, Rohan LC.

PLoS One. 2014 Jul 15;9(7):e102585. doi: 10.1371/journal.pone.0102585. eCollection 2014.

PMID:
25025306
[PubMed - in process]
Free PMC Article
2.

Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal Raman spectroscopy.

Chuchuen O, Henderson MH, Sykes C, Kim MS, Kashuba AD, Katz DF.

PLoS One. 2013 Dec 30;8(12):e85124. doi: 10.1371/journal.pone.0085124. eCollection 2013.

PMID:
24386455
[PubMed - in process]
Free PMC Article
3.

Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.

Bon I, Lembo D, Rusnati M, Clò A, Morini S, Miserocchi A, Bugatti A, Grigolon S, Musumeci G, Landolfo S, Re MC, Gibellini D.

PLoS One. 2013 Oct 7;8(10):e76482. doi: 10.1371/journal.pone.0076482. eCollection 2013.

PMID:
24116111
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.

Chaowanachan T, Krogstad E, Ball C, Woodrow KA.

PLoS One. 2013 Apr 22;8(4):e61416. doi: 10.1371/journal.pone.0061416. Print 2013.

PMID:
23630586
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice.

Chateau ML, Denton PW, Swanson MD, McGowan I, Garcia JV.

PLoS One. 2013;8(3):e60024. doi: 10.1371/journal.pone.0060024. Epub 2013 Mar 20.

PMID:
23527295
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HIV-1 infection of female genital tract tissue for use in prevention studies.

Dezzutti CS, Uranker K, Bunge KE, Richardson-Harman N, Macio I, Hillier SL.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):548-54. doi: 10.1097/QAI.0b013e318291f331.

PMID:
23514957
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus.

McElrath MJ, Smythe K, Randolph-Habecker J, Melton KR, Goodpaster TA, Hughes SM, Mack M, Sato A, Diaz G, Steinbach G, Novak RM, Curlin ME, Lord JD, Maenza J, Duerr A, Frahm N, Hladik F; NIAID HIV Vaccine Trials Network.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):263-71. doi: 10.1097/QAI.0b013e3182898392. Erratum in: J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):323. Curlin, M [corrected to Curlin, Marcel E].

PMID:
23392465
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Drug-eluting fibers for HIV-1 inhibition and contraception.

Ball C, Krogstad E, Chaowanachan T, Woodrow KA.

PLoS One. 2012;7(11):e49792. doi: 10.1371/journal.pone.0049792. Epub 2012 Nov 28.

PMID:
23209601
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity.

Dezzutti CS, Brown ER, Moncla B, Russo J, Cost M, Wang L, Uranker K, Kunjara Na Ayudhya RP, Pryke K, Pickett J, Leblanc MA, Rohan LC.

PLoS One. 2012;7(11):e48328. doi: 10.1371/journal.pone.0048328. Epub 2012 Nov 7.

PMID:
23144863
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Rectal microbicide development.

McGowan I.

Curr Opin HIV AIDS. 2012 Nov;7(6):526-33. doi: 10.1097/COH.0b013e3283582bc2. Review.

PMID:
23032732
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention.

Dezzutti CS, Shetler C, Mahalingam A, Ugaonkar SR, Gwozdz G, Buckheit KW, Buckheit RW Jr.

Antiviral Res. 2012 Nov;96(2):221-5. doi: 10.1016/j.antiviral.2012.08.004. Epub 2012 Aug 23.

PMID:
22940075
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study.

Richardson-Harman N, Mauck C, McGowan I, Anton P.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1422-33. doi: 10.1089/AID.2012.0073. Epub 2012 Sep 20.

PMID:
22900504
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.

Gupta P, Ratner D, Ding M, Patterson B, Rohan LC, Reinhart TA, Ayyavoo V, Huang X, Patton DL, Ramratnam B, Cole AM.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):455-61.

PMID:
22592582
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.

Cost M, Dezzutti CS, Clark MR, Friend DR, Akil A, Rohan LC.

Antimicrob Agents Chemother. 2012 Jun;56(6):3058-66. doi: 10.1128/AAC.06284-11. Epub 2012 Mar 19.

PMID:
22430977
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy.

Anton PA, Saunders T, Elliott J, Khanukhova E, Dennis R, Adler A, Cortina G, Tanner K, Boscardin J, Cumberland WG, Zhou Y, Ventuneac A, Carballo-Diéguez A, Rabe L, McCormick T, Gabelnick H, Mauck C, McGowan I.

PLoS One. 2011;6(9):e23243. doi: 10.1371/journal.pone.0023243. Epub 2011 Sep 28.

PMID:
21969851
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.

Price CF, Tyssen D, Sonza S, Davie A, Evans S, Lewis GR, Xia S, Spelman T, Hodsman P, Moench TR, Humberstone A, Paull JR, Tachedjian G.

PLoS One. 2011;6(9):e24095. doi: 10.1371/journal.pone.0024095. Epub 2011 Sep 15.

PMID:
21935377
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Humanized mouse models of HIV infection.

Denton PW, García JV.

AIDS Rev. 2011 Jul-Sep;13(3):135-48. Review.

PMID:
21799532
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.

Telwatte S, Moore K, Johnson A, Tyssen D, Sterjovski J, Aldunate M, Gorry PR, Ramsland PA, Lewis GR, Paull JR, Sonza S, Tachedjian G.

Antiviral Res. 2011 Jun;90(3):195-9. doi: 10.1016/j.antiviral.2011.03.186. Epub 2011 Apr 1.

PMID:
21459115
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations.

Wang L, Schnaare RL, Dezzutti C, Anton PA, Rohan LC.

AIDS Res Ther. 2011 Mar 7;8:12. doi: 10.1186/1742-6405-8-12.

PMID:
21385339
[PubMed]
Free PMC Article
20.

Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Merbah M, Introini A, Fitzgerald W, Grivel JC, Lisco A, Vanpouille C, Margolis L.

Am J Reprod Immunol. 2011 Mar;65(3):268-78. doi: 10.1111/j.1600-0897.2010.00967.x. Epub 2011 Jan 12.

PMID:
21223429
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk